Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Clinical trial NCT01295515 · COMPLETED
Trial details
- NCT number
- NCT01295515
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-11
- Primary completion
- 2017-05-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.